PT  - JOURNAL ARTICLE
AU  - Aldo L. Schenone
AU  - A. Michael Lincoff
TI  - Aspirin for primary prevention of atherosclerotic cardiovascular events
AID  - 10.3949/ccjm.87a.19045
DP  - 2020 May 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 300--311
VI  - 87
IP  - 5
4099  - http://www.ccjm.org/content/87/5/300.short
4100  - http://www.ccjm.org/content/87/5/300.full
SO  - Cleve Clin J Med2020 May 01; 87
AB  - Recent trials evaluated the impact of aspirin for primary prevention of cardiovascular events in patients at intermediate risk, patients with diabetes, and the elderly, and the results have been incorporated into the most recent professional guidelines. For the most part, the role of aspirin in primary prevention remains limited, albeit not adequately tested in those at higher risk.